TAMBE Japan Post-Marketing Surveillance

Recruiting now

Conditions studied: Thoracoabdominal Aortic Aneurysm, Pararenal Aortic Aneurysm

In brief

To evaluate the safety and efficacy of multi component system (TAMBE device) including GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (Aortic Component; AC) under post-marketing use.

Key facts

Study ID

NCT07147569

Run by

W.L.Gore & Associates

People needed

100

Starts

2026-03-27

Expected to finish

2034-02-28

Last updated by the study team

2026-05-05

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who were attempted to implant the AC
• Thoracoabdominal aortic aneurysm
• Pararenal abdominal aortic aneurysm

You may not qualify if…

• N/A

Where it is running

• The Jikei University Hospital — Minatoku, Japan (enrolling)
• Nagoya University Hospital — Nagoya, Japan (enrolling)
• Morinomiya Hospital — Osaka, Japan (enrolling)
• Osaka International Medical & Science Center Osaka Police Hospital — Osaka, Japan (enrolling)
• The University of Osaka Hospital — Suita, Japan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.